Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues.

Lacombe J, Ferron M.

Nutrients. 2018 Jul 26;10(8). pii: E970. doi: 10.3390/nu10080970. Review.

2.

Loss of OcaB Prevents Age-Induced Fat Accretion and Insulin Resistance by Altering B-Lymphocyte Transition and Promoting Energy Expenditure.

Carter S, Miard S, Caron A, Sallé-Lefort S, St-Pierre P, Anhê FF, Lavoie-Charland E, Blais-Lecours P, Drolet MC, Lefebvre JS, Lacombe J, Deshaies Y, Couet J, Laplante M, Ferron M, Bossé Y, Marette A, Richard D, Marsolais D, Picard F.

Diabetes. 2018 Jul;67(7):1285-1296. doi: 10.2337/db17-0558. Epub 2018 Mar 1.

PMID:
29496744
3.

VKOR paralog VKORC1L1 supports vitamin K-dependent protein carboxylation in vivo.

Lacombe J, Rishavy MA, Berkner KL, Ferron M.

JCI Insight. 2018 Jan 11;3(1). pii: 96501. doi: 10.1172/jci.insight.96501. [Epub ahead of print]

4.

Proprotein convertase furin regulates osteocalcin and bone endocrine function.

Al Rifai O, Chow J, Lacombe J, Julien C, Faubert D, Susan-Resiga D, Essalmani R, Creemers JW, Seidah NG, Ferron M.

J Clin Invest. 2017 Nov 1;127(11):4104-4117. doi: 10.1172/JCI93437. Epub 2017 Oct 3.

5.

Regulation of Energy Metabolism by Bone-Derived Hormones.

Mera P, Ferron M, Mosialou I.

Cold Spring Harb Perspect Med. 2018 Jun 1;8(6). pii: a031666. doi: 10.1101/cshperspect.a031666. Review.

PMID:
28778968
6.

Metabolic phenotype in the mouse model of osteogenesis imperfecta.

Boraschi-Diaz I, Tauer JT, El-Rifai O, Guillemette D, Lefebvre G, Rauch F, Ferron M, Komarova SV.

J Endocrinol. 2017 Sep;234(3):279-289. doi: 10.1530/JOE-17-0335. Epub 2017 Jul 17.

PMID:
28716975
7.

Matrix Gla protein deficiency impairs nasal septum growth, causing midface hypoplasia.

Marulanda J, Eimar H, McKee MD, Berkvens M, Nelea V, Roman H, Borrás T, Tamimi F, Ferron M, Murshed M.

J Biol Chem. 2017 Jul 7;292(27):11400-11412. doi: 10.1074/jbc.M116.769802. Epub 2017 May 9.

8.

Association between osteocalcin gamma-carboxylation and insulin resistance in overweight and obese postmenopausal women.

Bonneau J, Ferland G, Karelis AD, Doucet É, Faraj M, Rabasa-Lhoret R, Ferron M.

J Diabetes Complications. 2017 Jun;31(6):1027-1034. doi: 10.1016/j.jdiacomp.2017.01.023. Epub 2017 Feb 13.

PMID:
28242268
9.

Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise.

Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, Torsitano C, McGraw TE, Puchowicz M, Kurland I, Karsenty G.

Cell Metab. 2017 Jan 10;25(1):218. doi: 10.1016/j.cmet.2016.12.003. No abstract available.

10.

Osteocalcin Signaling in Myofibers Is Necessary and Sufficient for Optimum Adaptation to Exercise.

Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, Bacchetta J, Szulc P, Kitsis RN, de Cabo R, Friedman RA, Torsitano C, McGraw TE, Puchowicz M, Kurland I, Karsenty G.

Cell Metab. 2016 Jun 14;23(6):1078-1092. doi: 10.1016/j.cmet.2016.05.004. Erratum in: Cell Metab. 2017 Jan 10;25(1):218.

11.

Gamma-carboxylation regulates osteocalcin function.

Lacombe J, Ferron M.

Oncotarget. 2015 Aug 21;6(24):19924-5. No abstract available.

12.

Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone.

Oropeza D, Jouvet N, Budry L, Campbell JE, Bouyakdan K, Lacombe J, Perron G, Bergeron V, Neuman JC, Brar HK, Fenske RJ, Meunier C, Sczelecki S, Kimple ME, Drucker DJ, Screaton RA, Poitout V, Ferron M, Alquier T, Estall JL.

Diabetes. 2015 Nov;64(11):3798-807. doi: 10.2337/db15-0272. Epub 2015 Jul 7.

13.

Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis.

Oury F, Ferron M, Huizhen W, Confavreux C, Xu L, Lacombe J, Srinivas P, Chamouni A, Lugani F, Lejeune H, Kumar TR, Plotton I, Karsenty G.

J Clin Invest. 2015 May;125(5):2180. doi: 10.1172/JCI81812. Epub 2015 May 1. No abstract available.

14.

GGCX and VKORC1 inhibit osteocalcin endocrine functions.

Ferron M, Lacombe J, Germain A, Oury F, Karsenty G.

J Cell Biol. 2015 Mar 16;208(6):761-76. doi: 10.1083/jcb.201409111. Epub 2015 Mar 9.

15.

Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes.

Huesa C, Zhu D, Glover JD, Ferron M, Karsenty G, Milne EM, Millan JL, Ahmed SF, Farquharson C, Morton NM, MacRae VE.

Dis Model Mech. 2014 Dec;7(12):1341-50. doi: 10.1242/dmm.017905. Epub 2014 Oct 31.

16.

FGF-21 and skeletal remodeling during and after lactation in C57BL/6J mice.

Bornstein S, Brown SA, Le PT, Wang X, DeMambro V, Horowitz MC, MacDougald O, Baron R, Lotinun S, Karsenty G, Wei W, Ferron M, Kovacs CS, Clemmons D, Wan Y, Rosen CJ.

Endocrinology. 2014 Sep;155(9):3516-26. doi: 10.1210/en.2014-1083. Epub 2014 Jun 10.

17.

Regulation of energy metabolism by the skeleton: osteocalcin and beyond.

Ferron M, Lacombe J.

Arch Biochem Biophys. 2014 Nov 1;561:137-46. doi: 10.1016/j.abb.2014.05.022. Epub 2014 Jun 2. Review.

PMID:
24893146
18.

Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation.

Wei J, Ferron M, Clarke CJ, Hannun YA, Jiang H, Blaner WS, Karsenty G.

J Clin Invest. 2014 Apr;124(4):1-13. doi: 10.1172/JCI72323. Epub 2014 Mar 18.

19.

Tsc2 is a molecular checkpoint controlling osteoblast development and glucose homeostasis.

Riddle RC, Frey JL, Tomlinson RE, Ferron M, Li Y, DiGirolamo DJ, Faugere MC, Hussain MA, Karsenty G, Clemens TL.

Mol Cell Biol. 2014 May;34(10):1850-62. doi: 10.1128/MCB.00075-14. Epub 2014 Mar 3.

20.

In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice.

Lacombe J, Karsenty G, Ferron M.

Mol Metab. 2013 Aug 15;2(4):498-504. doi: 10.1016/j.molmet.2013.08.004. eCollection 2013.

Supplemental Content

Loading ...
Support Center